Table 2.
Comparison of ApoA1, ApoB, and ApoA1/B Ratio Between Control Group and Experiment Group
| Indices | Control (N=41) | COPD Without Acute Lower Respiratory Tract Infection (N=35) | COPD Complicated by Acute Lower Respiratory Tract Infection (N=171) | Pa | Pb | Pc |
|---|---|---|---|---|---|---|
| ApoA1 (g/L) | 1.32±0.14 | 1.30±0.24 | 0.94±0.25 | 0.69 | *** | *** |
| ApoB (g/L) | 0.80±0.12 | 0.80±0.18 | 0.68±0.19 | 0.81 | *** | *** |
| ApoA1/ B | 1.61±0.32 | 1.67±0.43 | 1.47±0.50 | 0.66 | ** | ** |
Notes: Pa: Healthy controls vs COPD patients without acute lower respiratory tract infection; Pb: Healthy controls vs COPD patients with acute lower respiratory tract infection; Pc: COPD patients without acute lower respiratory tract infection vs COPD patients with acute lower respiratory tract infection. ***P<0.001; **P<0.01.
Abbreviations: ApoA1, apolipoprotein A1; ApoB, apolipoprotein B; ApoA1/ B, apolipoprotein A1/apolipoprotein B.